Description

Product Name	CLA Glycerides 60% Microencapsulated Powder CWD
Full Ingredient Name	Conjugated Linoleic Acid Glycerides
Product Category	Nutritional Lipid Ingredient
Available Grade	40% / 60% CWD
Product Positioning	60% CLA Glycerides Microencapsulated Powder
CLA Glycerides Content	540–620 mg/g
Total Fat	60% / 70% min.
Physical Form	Powder
Product Format	Microencapsulated Powder
Water Performance	CWD (Cold Water Dispersible)
Processing Technology	Microencapsulation Technology
Main Application	Dietary supplements, nutritional beverages, functional foods, nutritional powders and premixes

CLA Glycerides 60% Microencapsulated Powder CWD is designed for manufacturers that require a higher-concentration conjugated linoleic acid glycerides ingredient in a convenient powdered format. The product combines a relatively high lipid content with Cold Water Dispersible performance, allowing it to be considered for both dry powder formulations and water-based nutritional systems.

1.1Conjugated Linoleic Acid Glycerides Content: 540–620 mg/g
The specified CLA glycerides content is 540–620 mg/g, providing a defined active lipid range for formulation and quality control. This specification can be used by manufacturers when calculating ingredient dosage and the corresponding contribution of CLA glycerides to the finished product.

1.2Total Fat: 60% / 70% Minimum
The product is specified with 60% / 70% minimum total fat, depending on the corresponding grade or specification. This provides a higher-fat powdered ingredient format for formulations requiring a concentrated nutritional lipid component.

1.3 40% / 60% CWD Grades
The product specification includes 40% / 60% CWD grades, giving manufacturers options according to the required product design, dosage level and processing system. The appropriate grade can be selected according to the target formulation and application.

 

2.CWD — Cold Water Dispersible
CWD means Cold Water Dispersible. The powder is designed to disperse in cold water, which makes it suitable for powdered beverages, nutritional drink mixes and other formulations where dispersion in an aqueous system is required. CWD should not automatically be interpreted as completely water-soluble.

2.1Microencapsulation Technology
CLA glycerides are lipid-based ingredients, while conventional lipid ingredients are generally supplied in oil or liquid forms. Microencapsulation Technology enables the lipid ingredient to be processed into a powder format, providing greater convenience for dry blending, weighing, transportation and formulation.

 

3.Convenient Powder Processing
The microencapsulated powder format is suitable for standard powder-handling processes, including weighing, blending and premix preparation. This can simplify the incorporation of CLA glycerides into finished powdered products compared with handling a conventional liquid lipid ingredient.

 

4.1Suitable for Water-Based Formulations
The CWD format provides greater formulation flexibility for products that require a dispersible lipid ingredient. It can be considered for nutritional beverages, powdered drink mixes and other water-based nutritional products.

4.2Suitable for Dry Formulations
The powder format can also be incorporated into dry-blend systems such as nutritional powders, supplement powders and premixes. This makes the product suitable for manufacturers working across different product formats.

4.3Formulation Flexibility
The available grades and defined active-content range allow manufacturers to select an appropriate specification according to the desired dosage, product format and nutritional formulation.

 

5.Advanced Ingredient Technology Platform
Although this product uses Microencapsulation Technology, our broader technology platform includes Liposomal Technology, Pellet Technology, Granulation Technology, Submicroencapsulation Technology, Cocrystal Technology, and Co-amorphous Technology. Different technologies can be considered according to the physicochemical properties of the active ingredient, target dosage form and finished-product requirements.

 

6.Key Product Characteristics

6.1High-Concentration CLA Glycerides Powder
Designed as a concentrated microencapsulated CLA glycerides ingredient for nutritional and functional formulations.

6.2 540–620 mg/g CLA Glycerides
Provides a defined CLA glycerides content range for formulation calculation and quality control.

6.3 60% / 70% Minimum Total Fat
Provides a high-fat powdered ingredient format suitable for nutritional lipid applications.

6.4Cold Water Dispersible
CWD performance supports dispersion in cold-water systems and expands the potential application range beyond conventional dry formulations.

6.5Microencapsulated Powder Format
Provides a convenient powder form for handling, blending and incorporation into finished products.

6.6Multiple Grade Options
40% / 60% CWD grades provide flexibility for different formulation requirements.

 

7.Why Choose CLA Glycerides 60% Microencapsulated Powder CWD?

• 540–620 mg/g conjugated linoleic acid glycerides
• 60% / 70% minimum total fat specification
• 40% / 60% CWD grade options
• Cold Water Dispersible format
• Microencapsulated CLA glycerides powder
• Higher-concentration nutritional lipid ingredient
• Suitable for dry and water-based formulations
• Convenient for powder blending and premix production
• Suitable for nutritional beverages and powdered drinks
• Suitable for dietary supplements and functional foods
• OEM and customized ingredient development available

 

8.Applications

8.1Dietary Supplements

Suitable for dietary supplement powders, nutritional blends, sachets and other supplement products requiring a concentrated CLA glycerides ingredient in powder form.

8.2Nutritional Beverages

The CWD format makes the product suitable for nutritional beverage systems and powdered drink products where dispersion in cold water is required.

8.3Powdered Drink Mixes

Can be incorporated into instant nutritional drink powders and other dry beverage formulations.

8.4Functional Foods

Suitable for functional food and nutrition-focused formulations requiring a nutritional lipid ingredient.

8.5Nutritional Powders

The powder format can be incorporated into nutritional powders, meal replacement products and other dry-blend systems.

8.6Nutritional Premixes

Suitable for nutritional premixes and ingredient blends where CLA glycerides need to be incorporated as part of a dry formulation system.

 

9.Supply & Customized Processing

We supply CLA Glycerides 60% Microencapsulated Powder CWD for bulk ingredient supply, formulation development and customized processing.

Customization can be discussed according to the target application, including CLA glycerides concentration, total fat content, CWD performance, powder characteristics, particle characteristics, packaging and application-specific specifications.

Our advanced ingredient technology platform includes:

• Liposomal Technology
• Pellet Technology
• Granulation Technology
• Microencapsulation Technology
• Submicroencapsulation Technology
• Cocrystal Technology
• Co-amorphous Technology

For the present product, Microencapsulation Technology is used to develop CLA glycerides into a convenient powdered ingredient, while the CWD design provides Cold Water Dispersible performance.

For other active ingredients or different formulation objectives, we can evaluate alternative technologies such as Liposomal, Pellet, Granulation, Submicroencapsulation, Cocrystal or Co-amorphous Technologies according to the specific technical requirements.

 

10.Certifications & Technical Documentation

Depending on the product specification and destination market, supporting documentation may include:

• Certificate of Analysis (COA)
• Product Specification
• Safety Data Sheet (SDS/MSDS)
• Product Information Sheet
• Allergen Statement, where applicable
• Non-GMO Statement, where applicable
• Vegan Statement, where applicable
• Kosher / Halal documentation, where applicable

 

FAQ

1.What is CLA Glycerides 60% Microencapsulated Powder CWD?
It is a microencapsulated conjugated linoleic acid glycerides powder designed in a CWD (Cold Water Dispersible) format, with a specified CLA glycerides content of 540–620 mg/g.

2.What is the CLA glycerides content?
The specified content is 540–620 mg/g conjugated linoleic acid glycerides.

3.What is the total fat content?
The product specification indicates 60% / 70% minimum total fat, depending on the corresponding grade or specification.

4.What does CWD mean?
CWD means Cold Water Dispersible. The product is designed to disperse in cold water and should not automatically be described as completely water-soluble.

5.What grades are available?
The supplied specification indicates 40% / 60% CWD grades.

6.Why is CLA glycerides made into a microencapsulated powder?
Microencapsulation converts the lipid ingredient into a convenient powder format, making it easier to handle, blend and incorporate into dry and water-based nutritional formulations.

7.What applications are suitable for this product?
The product can be used in dietary supplements, nutritional beverages, powdered drink mixes, functional foods, nutritional powders and nutritional premixes.

8.What technologies can be used for customized ingredients?
In addition to Microencapsulation Technology, our broader platform includes Liposomal, Pellet, Granulation, Submicroencapsulation, Cocrystal and Co-amorphous Technologies. The appropriate technology can be evaluated according to the active ingredient and target formulation.

9.Can the specification be customized?
Customized specifications can be discussed according to the customer’s formulation, application and production requirements.

10.Can samples and technical documents be provided?
Yes. Samples, COA, technical specifications and other supporting documents can be provided according to customer requirements.